Medscape Newsfeed:
- Active Surveillance Rises as Focal Therapy Persists
Surveillance has surged for favorable-risk prostate cancer, but focal therapy remains in use despite limited evidence and limited guideline support. Medscape Medical News
- Best Treatments for BD: Current Evidence, New Online Tool
A ‘living’ evidence review of bipolar disorder treatments has been transformed into a free, continuously updated online tool that helps clinicians and patients weigh efficacy, side effects, and individual preferences. Medscape Medical News
- APOE epsilon 4 Flags ARIA Risk but Falls Short as Predictor
Real-world lecanemab findings show that APOE epsilon 4 status identifies patients at a higher risk for ARIA but cannot predict which individuals will develop the complication. Medscape Medical News
- Add-On Citicoline May Improve Motor Function in PD
Citicoline added to dopaminergic therapy is safe and tied to higher odds of clinically meaningful improvement than placebo in motor function in Parkinson’s, a trial shows. Medscape Medical News
- Up the Ante for Lung Cancer Screening in Women
Rising incidence calls for more recognition of lung cancer risks in nonsmoking women. Medscape Medical News
NIH Newsfeed:
- Elevated use of cannabis, nicotine among U.S. adults continues into 2025
National survey suggests that use of alcohol, cigarettes, and other substances remains low.
- Virtual intervention reduces substance use in American Indians and Alaska Natives
Emerging adults who participated in workshops combining evidence-based interventions and traditional practices reported reduced cannabis, alcohol use, and anxiety.
- NIH selects Dr. Judy Cho to helm the National Human Genome Research Institute
Dr. Cho joins NIH from the Icahn School of Medicine at Mount Sinai in New York City.
- Human cancer models to accelerate research and precision therapies
NIH-funded international research collaboration catalogues 25 tumor types from thousands of patient donors.